Thymic selection generates a large T cell pool recognizing a self-peptide in humans

Journal of Experimental Medicine

Volumn 195, Issue 4, 2002, Pages 485-494

  Zippelius, Alfred ^a   Pittet, Mikaël J ^a   Batard, Pascal ^a   Rufer, Nathalie ^b   De Smedt, Magda ^c   Guillaume, Philippe ^d   Ellefsen, Kim ^a   Valmori, Danila ^a   Liénard, Danielle ^a   Plum, Jean ^c   Robson MacDonald, H ^d   Speiser, Daniel E ^a   Cerottini, Jean Charles ^d   Romero, Pedro ^a,e  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e Hopital Orthopedique de la Suisse Romande   (Switzerland)

Author keywords

CD8; Melan=A MART 1; Naive; Telomere; TREC

Indexed keywords

HLA A2 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOPOIESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TELOMERE; THYMOCYTE; THYMUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; AUTOANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GENE REARRANGEMENT, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HUMANS; IMMUNOLOGIC MEMORY; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; STEM CELLS; TELOMERE; THYMUS GLAND;

EID: 0037128179     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011658     Document Type: Article

References (50)

1. Selecting and maintaining a diverse T-cell repertoire
2. The thymus and central tolerance
3. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity
4. Tracing and characterization of the low-avidity self-specific T cell repertoire
5. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery
6. Designing and maintaining the mature TCR repertoire: The continuum of self-peptide:self-MHC complex recognition
7. Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency
8. Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes
9. A very high level of crossreactivity is an essential feature of the T-cell receptor
10. Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion
11. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
12. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
13. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
14. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma
15. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
16. Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide
17. + T cells in a large proportion of human histocompatibility, leukocyte antigen (HLA)-A2 individuals
18. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response
19. Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: Implications of a novel approach for T cell monitoring in infectious and malignant diseases
20. Antigenin-dependent activation of naive and memory resting T cells by a cytokine combination
21. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation
22. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells
23. Cutting edge: Naive T cells masquerading as memory cells
24. Identical expression of CD45R isoforms by CD45RC+ 'revertant' memory and CD451kC+ naive CD4 T cells
25. Changes in thymic function with age and during the treatment of HIV infection
26. Direct evidence for thymic function in adult humans
27. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
28. Preferential rearrangements of the T cell receptor-delta-deleting elements in human T cells
29. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry
30. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood
31. Human naïve and memory T lymphocytes differ in telomeric length and replicative potential
32. Phenotypic analysis of antigen-specific T lymphocytes
33. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
34. CD8+ T cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences
35. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
36. A simplified procedure for the preparation of MHC/peptide tetramers: Chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I
37. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
38. Random entry of circulating lymphocyte subsets into peripheral lymph nodes and Peyer's patches: No evidence in vivo of a tissue-specific migration of B and T lymphocytes at the level of high endothelial venules
39. Memory CD8+ T cell differentiation: Initial antigen encounter triggers a developmental program in naive cells
40. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)
41. Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35)
42. Requirement for diverse, low-abundance peptides in positive selection of T cells
43. Self-antigen presentation by thymic stromal cells: A subtle division of labor
44. Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires
45. Self-ignorance in the peripheral T-cell pool
46. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice
47. Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients
48. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
49. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
50. HLA-A2 restricted, melanocytespecific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1